These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 35346832)
1. K Gertler TS; Cherian S; DeKeyser JM; Kearney JA; George AL Neurobiol Dis; 2022 Jun; 168():105713. PubMed ID: 35346832 [TBL] [Abstract][Full Text] [Related]
2. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855 [TBL] [Abstract][Full Text] [Related]
3. Heterozygous expression of a Shore AN; Li K; Safari M; Qunies AM; Spitznagel BD; Weaver CD; Emmitte K; Frankel W; Weston MC Elife; 2024 Oct; 13():. PubMed ID: 39392867 [TBL] [Abstract][Full Text] [Related]
4. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures. Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692 [TBL] [Abstract][Full Text] [Related]
5. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum. Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611 [TBL] [Abstract][Full Text] [Related]
7. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261 [TBL] [Abstract][Full Text] [Related]
8. Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons. Wu J; Quraishi IH; Zhang Y; Bromwich M; Kaczmarek LK Cell Rep; 2024 Mar; 43(3):113904. PubMed ID: 38457342 [TBL] [Abstract][Full Text] [Related]
9. New use for an old drug: quinidine in KCNT1-related epilepsy therapy. Liu R; Sun L; Wang Y; Wang Q; Wu J Neurol Sci; 2023 Apr; 44(4):1201-1206. PubMed ID: 36437393 [TBL] [Abstract][Full Text] [Related]
17. Discovery of the First Orally Available, Selective K Griffin AM; Kahlig KM; Hatch RJ; Hughes ZA; Chapman ML; Antonio B; Marron BE; Wittmann M; Martinez-Botella G ACS Med Chem Lett; 2021 Apr; 12(4):593-602. PubMed ID: 33859800 [TBL] [Abstract][Full Text] [Related]
18. The Epilepsy of Infancy With Migrating Focal Seizures: Identification of Mao X; Bruneau N; Gao Q; Becq H; Jia Z; Xi H; Shu L; Wang H; Szepetowski P; Aniksztejn L Front Cell Neurosci; 2020; 14():1. PubMed ID: 32038177 [TBL] [Abstract][Full Text] [Related]
19. Functional evaluation of epilepsy-associated KCNT1 variants in multiple cellular systems reveals a predominant gain of function impact on channel properties. Hinckley CA; Zhu Z; Chu JH; Gubbels C; Danker T; Cherry JJ; Whelan CD; Engle SJ; Nguyen V Epilepsia; 2023 Aug; 64(8):2126-2136. PubMed ID: 37177976 [TBL] [Abstract][Full Text] [Related]
20. Heterozygous expression of a Shore AN; Li K; Safari M; Qunies AM; Spitznagel BD; Weaver CD; Emmitte KA; Frankel WN; Weston MC bioRxiv; 2024 Aug; ():. PubMed ID: 37873369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]